AstraZeneca

NEWS

Drug Development

Biopharma Update on the Novel Coronavirus: June 17

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.

June 16, 2020

5 min read

BioSpace Editorial Staff

Courtesy of Alexanderstock23/Shutterstock

Job Trends

AstraZeneca Strikes Deal with European Nations to Supply 400 Million Doses of COVID-19 Vaccine

The U.K. pharma giant struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of the preventative medication by the end of 2020 – if it clears the clinic.

June 15, 2020

3 min read

Alex Keown

Policy

Biopharma Update on the Novel Coronavirus: June 15

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 15, 2020.

June 15, 2020

3 min read

BioSpace Editorial Staff

BioCapital

Clinical Catch-Up: June 8-12

It was a fairly busy week with clinical trial updates and announcements. Here’s a look.

June 12, 2020

12 min read

Mark Terry

Drug Development

Biopharma Update on the Novel Coronavirus: June 12

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 12, 2020.

June 11, 2020

4 min read

BioSpace Editorial Staff

Drug Development

Biopharma Update on the Novel Coronavirus: June 10

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 10, 2020.

June 10, 2020

4 min read

BioSpace Editorial Staff

Drug Development

AstraZeneca’s Blood Cancer Drug Calquence May Benefit Severely-Ill COVID-19 Patients

Researchers with The U.S. Oncology Network discovered AstraZeneca’s Calquence (acalabrutinib) benefited a small number of patients who have severe infections of the novel coronavirus.

June 8, 2020

3 min read

Alex Keown

Policy

Biopharma Update on the Novel Coronavirus: June 8

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.

June 8, 2020

3 min read

BioSpace Editorial Staff

Deals

Report: AstraZeneca Eyes Gilead Sciences for Potential Merger

Shares of Gilead Sciences jumped in pre-market trading this weekend following reports that the company has been approached by U.K. pharma giant AstraZeneca regarding a potential merger.

June 8, 2020

3 min read

Alex Keown

AWARDS